Comparative effectiveness of everolimus and axitinib as second targeted therapies for metastatic renal cell carcinoma in the US: a retrospective chart review. [electronic resource]
Producer: 20161213Description: 741-7 p. digitalISSN:- 1473-4877
- Aged
- Animals
- Antineoplastic Agents -- administration & dosage
- Axitinib
- Carcinoma, Renal Cell -- drug therapy
- Comparative Effectiveness Research
- Disease-Free Survival
- Everolimus -- administration & dosage
- Female
- Humans
- Imidazoles -- administration & dosage
- Indazoles -- administration & dosage
- Indoles -- administration & dosage
- Kidney Neoplasms -- drug therapy
- Male
- Middle Aged
- Niacinamide -- administration & dosage
- Phenylurea Compounds -- administration & dosage
- Proportional Hazards Models
- Protein Kinase Inhibitors -- administration & dosage
- Pyrimidines -- administration & dosage
- Pyrroles -- administration & dosage
- Retrospective Studies
- Sirolimus -- administration & dosage
- Sorafenib
- Sulfonamides -- administration & dosage
- Sunitinib
- Treatment Outcome
- United States
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.